Literature DB >> 27890787

Inflammatory Linear Verrucous Epidermal Nevus with a Postzygotic GJA1 Mutation Is a Mosaic Erythrokeratodermia Variabilis et Progressiva.

Noriko Umegaki-Arao1, Takashi Sasaki2, Harumi Fujita3, Satomi Aoki1, Kaori Kameyama4, Masayuki Amagai3, Mariko Seishima5, Akiharu Kubo6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27890787     DOI： 10.1016/j.jid.2016.11.016

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  5 in total

1.  Life-long Skin Eruptions along Blaschko's Lines in a 27-year-old Woman: A Quiz.

Authors:  Takahiro Hamada; Kwesi Teye; Eri Katayama; Miyuki Kawamura; Hiroshi Koga; Norito Ishii; Takekuni Nakama
Journal:  Acta Derm Venereol       Date:  2021-12-07       Impact factor: 3.875

2.  Connexin43 mutations linked to skin disease have augmented hemichannel activity.

Authors:  Miduturu Srinivas; Thomas F Jannace; Anthony G Cocozzelli; Leping Li; Nefeli Slavi; Caterina Sellitto; Thomas W White
Journal:  Sci Rep       Date:  2019-01-10       Impact factor: 4.379

Review 3.  Connexin 43 Mutations Lead to Increased Hemichannel Functionality in Skin Disease.

Authors:  Anthony G Cocozzelli; Thomas W White
Journal:  Int J Mol Sci       Date:  2019-12-07       Impact factor: 5.923

4.  Interrogation of Carboxy-Terminus Localized GJA1 Variants Associated with Erythrokeratodermia Variabilis et Progressiva.

Authors:  Sergiu A Lucaciu; Qing Shao; Rhett Figliuzzi; Kevin Barr; Donglin Bai; Dale W Laird
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

5.  Molecular Genetic Dissection of Inflammatory Linear Verrucous Epidermal Naevus Leads to Successful Targeted Therapy.

Authors:  Melissa Riachi; Satyamaanasa Polubothu; Paulina Stadnik; Connor Hughes; Sara Barberan Martin; Carolyn R Charman; Iek Leng Cheng; Karolina Gholam; Olumide Ogunbiyi; David G Paige; Neil J Sebire; Alan Pittman; Wei-Li Di; Veronica A Kinsler
Journal:  J Invest Dermatol       Date:  2021-06-08       Impact factor: 8.551
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.